Total Payments
$6,938
2024 Payments
$265.49
Companies
32
Transactions
321
Medicare Patients
6,831
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$6,809 (98.1%)
Education$128.97 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,809 | 316 | 98.1% |
| Education | $128.97 | 5 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,156 | 36 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $824.86 | 72 | $0 (2021) |
| Amgen Inc. | $716.31 | 48 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $686.89 | 47 | $0 (2023) |
| Medtronic Vascular, Inc. | $443.32 | 11 | $0 (2020) |
| Astellas Pharma US Inc | $292.02 | 16 | $0 (2018) |
| Boston Scientific Corporation | $281.67 | 5 | $0 (2024) |
| PFIZER INC. | $182.30 | 12 | $0 (2024) |
| Edwards Lifesciences Corporation | $169.16 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $161.47 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $265.49 | 8 | Boston Scientific Corporation ($149.55) |
| 2023 | $557.08 | 22 | Novartis Pharmaceuticals Corporation ($139.32) |
| 2022 | $199.01 | 12 | Abbott Laboratories ($43.28) |
| 2021 | $689.82 | 25 | Abbott Laboratories ($398.03) |
| 2020 | $701.03 | 18 | Abbott Laboratories ($538.17) |
| 2019 | $779.28 | 47 | Abbott Laboratories ($192.61) |
| 2018 | $1,799 | 85 | Abbott Laboratories ($520.72) |
| 2017 | $1,947 | 104 | Abbott Laboratories ($328.51) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: Catheters | ||||||
| 10/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiology | ||||||
| 09/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: General - Therapies_CRM | ||||||
| 07/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $59.33 | General |
| Category: General - Therapies_CRM | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/28/2024 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $58.05 | General |
| Category: General - Therapies_CRM | ||||||
| 11/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiology | ||||||
| 10/25/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/11/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/22/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 08/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2023 | Brainsway USA INC | — | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| 07/20/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: EndoVenous Therapies | ||||||
| 07/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/05/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2023 | Medtronic, Inc. | HARMONY (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Heart Valves | ||||||
| 04/17/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $24.26 | General |
| Category: Cardiovascular Device | ||||||
| 03/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,572 | 2,162 | $1.4M | $337,120 |
| 2022 | 24 | 1,688 | 2,978 | $1.3M | $321,685 |
| 2021 | 27 | 1,851 | 4,188 | $1.3M | $330,912 |
| 2020 | 26 | 1,720 | 3,928 | $1.5M | $373,788 |
Total Patients
6,831
Total Services
13,256
Medicare Billing
$1.4M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 98 | 100 | $382,200 | $95,975 | 25.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 78 | 78 | $307,455 | $79,838 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 351 | 569 | $175,821 | $49,343 | 28.1% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 20 | 20 | $183,607 | $35,987 | 19.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 136 | $87,312 | $18,892 | 21.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 104 | 415 | $95,786 | $17,508 | 18.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 18 | 18 | $36,557 | $11,380 | 31.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 107 | 107 | $23,112 | $5,523 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 87 | $18,183 | $5,031 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 24 | $9,960 | $2,784 | 28.0% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 20 | 20 | $13,812 | $2,707 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 246 | 254 | $12,192 | $2,481 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,063 | $2,182 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $7,725 | $1,792 | 23.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 27 | 27 | $17,334 | $1,364 | 7.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 25 | $4,200 | $1,219 | 29.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $11,232 | $976.80 | 8.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 78 | 98 | $2,940 | $610.54 | 20.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 12 | 12 | $1,760 | $455.76 | 25.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 18 | 18 | $1,424 | $348.48 | 24.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 20 | 20 | $1,451 | $348.43 | 24.0% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 19 | 19 | $828.21 | $171.76 | 20.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 12 | 12 | $1,848 | $162.96 | 8.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 12 | 12 | $876.00 | $28.44 | 3.2% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2023 | 12 | 12 | $18.00 | $8.41 | 46.7% |
About Dr. Michael Gutierrez, MD
Dr. Michael Gutierrez, MD is a Cardiovascular Disease healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518957927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gutierrez, MD has received a total of $6,938 in payments from pharmaceutical and medical device companies, with $265.49 received in 2024. These payments were reported across 321 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,809).
As a Medicare-enrolled provider, Gutierrez has provided services to 6,831 Medicare beneficiaries, totaling 13,256 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location El Paso, TX
- Active Since 10/26/2005
- Last Updated 08/05/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518957927
Products in Payments
- XARELTO (Drug) $824.86
- ENTRESTO (Drug) $555.16
- Corlanor (Drug) $458.68
- Quadra Assura CRT Defibrillator (Device) $422.37
- Repatha (Biological) $253.63
- Resolute (Device) $191.57
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $177.94
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $169.16
- Lexiscan (Drug) $164.51
- ELIQUIS (Drug) $161.18
- Allure Quadra RF CRT Pacemaker (Device) $160.70
- Vascepa (Drug) $155.99
- Allure CRT Pacemaker (Device) $136.39
- TurboHawk (Device) $136.25
- LEQVIO (Drug) $131.73
- CRT-Ds (Device) $121.16
- Unify Assura CRT Defibrillator (Device) $116.09
- Merlin Connectivity and Remote (Device) $115.40
- CardioMEMS HF System (Device) $108.71
- Fortify Assura, Ellipse ICD (Device) $108.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in El Paso
Dr. Mohammad Raja, Md, MD
Cardiovascular Disease — Payments: $419,675
Cardiovascular Disease $419,675
Tu Cao, Do, DO
Cardiovascular Disease — Payments: $103,141
Cardiovascular Disease $103,141
Mr. Edward Assi, D.o, D.O
Cardiovascular Disease — Payments: $100,993
Cardiovascular Disease $100,993
Oscar Munoz, Md, MD
Cardiovascular Disease — Payments: $64,052
Cardiovascular Disease $64,052
Ediberto Soto-Cora, M.d, M.D
Cardiovascular Disease — Payments: $47,917
Cardiovascular Disease $47,917
Dr. Arshad Ali, Md, MD
Cardiovascular Disease — Payments: $26,863
Cardiovascular Disease $26,863